Treating Hepatocellular Carcinoma With Sorafenib in Liver Transplant Patients: An Initial Experience

Parkin, 2001, Estimating the world cancer burden: Globocan 2000, Int J Cancer, 94, 153, 10.1002/ijc.1440 Altekruse, 2009, Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005, J Clin Oncol, 20, 1485, 10.1200/JCO.2008.20.7753 El-Serag, 2003, The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update, Ann Intern Med, 139, 817, 10.7326/0003-4819-139-10-200311180-00009 Bruix, 1997, Treatment of hepatocellular carcinoma, Hepatology, 25, 259, 10.1002/hep.510250201 Fan, 1999, Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths, Ann Surg, 229, 322, 10.1097/00000658-199903000-00004 McCormack, 2005, Surgical therapy of hepatocellular carcinoma, Eur J Gastroenterol Hepatol, 17, 497, 10.1097/00042737-200505000-00005 Llovet, 2005, Updated treatment approach to hepatocellular carcinoma, J Gastroenterol, 40, 225, 10.1007/s00535-005-1566-3 Llovet, 1999, Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation, Hepatology, 30, 1434, 10.1002/hep.510300629 Mazzaferro, 1996, Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis, N Engl J Med, 334, 693, 10.1056/NEJM199603143341104 Llovet, 2005, Resection and liver transplantation for hepatocellular carcinoma, Semin Liver Dis, 25, 181, 10.1055/s-2005-871198 Wilhelm, 2006, Discovery and development of sorafenib: a multikinase inhibitor for treating cancer, Nat Rev Drug Discov, 5, 835, 10.1038/nrd2130 Llovet, 2008, Sorafenib in advanced hepatocellular carcinoma, N Engl J Med, 359, 378, 10.1056/NEJMoa0708857